Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF

Cardiovascular Research

Volumn 71, Issue 3, 2006, Pages 455-465

  Misao, Yu ^a   Takemura, Genzou ^a   Arai, Masazumi ^a   Ohno, Takamasa ^a   Onogi, Hirohito ^a   Takahashi, Tomoyuki ^a   Minatoguchi, Shinya ^a   Fujiwara, Takako ^b   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

AMD3100; CXCR4 SDF 1 axis; G CSF; Myocardial infarction; Post infarct repair

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 INHIBITOR; GRANULOCYTE COLONY STIMULATING FACTOR; INTERSTITIAL COLLAGENASE; SODIUM CHLORIDE; STAT3 PROTEIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DRUG EFFECT; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; ISCHEMIA; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; STATISTICAL SIGNIFICANCE;

ANIMALS; BONE MARROW CELLS; CHEMOKINES, CXC; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMODYNAMIC PROCESSES; HETEROCYCLIC COMPOUNDS; LEUKOCYTE COUNT; MALE; MATRIX METALLOPROTEINASE 1; MYOCARDIAL INFARCTION; RABBITS; RECEPTORS, CXCR4; STAT3 TRANSCRIPTION FACTOR; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33746313191     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.05.002     Document Type: Article

References (29)

1. Olic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98 (2001) 10344-10349
2. Minatoguchi S., Takemura G., Chen X., Wang N., Uno Y., Koda M., et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109 (2004) 2572-2580
3. Harada M., Qin Y., Takano H., Minamino T., Zou Y., Toko H., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 11 (2005) 305-311
4. Kawamoto A., Gwon H., Iwaguro H., Iwaguro H., Yamaguchi J., Uchida S., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 (2001) 634-637
5. Kawamoto A., Gwon H., Tkebuchava T., Yamaguchi J., Nishimura H., Yoon Y., et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107 (2003) 461-468
6. Urbich C., and Dimmeler S. Endothelial progenitor cells characterization and role in vascular biology. Circ Res 95 (2004) 343-353
7. Simper D., Stalboerger P.G., Panetta C.J., Wang S., and Caplice N.M. Smooth muscle progenitor cells in human blood. Circulation 106 (2002) 1199-1204
8. +-enriched cell population into cardiomyocytes, endothelial cells and smooth muscle cells in vivo. Circulation 108 (2003) 2070-2073
9. Badorff C., Brandes R.P., Popp R., Rupp S., Urbich C., Aicher A., et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107 (2003) 1024-1032
10. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Tsutsumi Y., Ozono R., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104 (2001) 1046-1052
11. +-cells. Circ J 69 (2005) 763-765
12. Whillett B.J., Cannon C.A., and Hosie M.J. Expression of CXCR4 on feline peripheral blood mononuclear cells: effect of feline immunodeficiency virus infection. J Virol 77 (2003) 709-712
13. Aiuti A., Turchetto L., Cota M., Cipponi A., Brambilla A., Arcelloni C., et al. Human CD34 (+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus. Blood 94 (1999) 62-73
14. Abbott J.D., Huang Y., Liu D., Hickey R., Krause D.S., and Giordano F.J. Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110 (2004) 3300-3305
15. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., et al. Stromal cell-derived factor-1 on ex vivo expanded endothelial progenitor cell recruitment for ischemia neovascularization. Circulation 107 (2003) 1322-1328
16. + stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 110 (2004) 3213-3220
17. Hendrix C.W., Flexner C., MacFarland R., Giandomenico C., Fuchs E.J., Redpath G., et al. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother 44 (2000) 1667-1673
18. Liles W.C., Broxmeyer H.E., Rodger E., Wood B., Hibel K., Hangoc G., et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, CXCR4 antagonist. Blood 102 (2003) 2728-2730
19. Simmons G., Reeves J.D., McKnight Á., Dejucq N., Hibbitts S., Power C.A., et al. CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. J Virol 72 (1998) 8453-8457
20. Hatse S., Princen K., Bridger G., De Clercq E., and Schols D. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 527 (2002) 255-262
21. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362 (2003) 697-703
22. Petit I., Szyper-Kravitz M., Nagler A., Lahav M., Peled A., Habler L., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3 (2002) 687-694
23. Berger O., Gan X., Gujuluva C., Burns A.R., Sulur G., Stins M., et al. CXC and CC chemokine receptors on coronary and brain endothelia. Mol Med 5 (1999) 795-805
24. Li Y., Takemura G., Okada H., Miyata S., Esaki M., Maruyama R., et al. Treatment with granulocyte colony-stimulating factor ameliorates chronic heart failure. Lab Invest 86 (2006) 32-44
25. Mascareno E., El-Shafei M., Maulik N., Sato M., Guo Y., Das D.K., et al. JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Circulation 104 (2001) 325-329
26. Minamino K., Adachi Y., Okazaki M., Ito H., Togawa Y., Fujita K., et al. Macrophage colony-stimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization. Stem Cells 23 (2005) 347-354
27. Ince H., Petzsch M., Kleine H.D., Schmidt H., Rehders T., Korber T., et al. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 112 (2005) 3097-3106
28. Suzuki K., Nagashima K., Arai M., Uno Y., Misao Y., Takemura G., et al. Effect of granulocyte colony-stimulating factor treatment at a low dose but for a long duration in patients with coronary heart disease. Circ J 70 (2006) 430-437
29. Ripa RS, Jorgensen E, Wang Y, Thune JJ, Nilsson JC, Sondergaard L, et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction. Result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation [in press].